Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00274690 · ClinicalTrials.gov registry record · Phase 2
Post-Operative Nausea And Vomiting Study In Female Patients
A Phase 2 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 435
- Enrollment target
NCT00274690: Completed Phase 2 study, sponsored by GlaxoSmithKline.
NCT00274690 is a Phase 2 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 435 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (227% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00274690, a Phase 2 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 435 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine an effective dose of this NK-1 anti-emetic medication to prevent nausea and vomiting in females after surgery.
Interventions
- DRUG GW679769
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 435 participants |
| Start Date | 2005-02 |
| Est. Completion | 2005-08 |
| Phase | Phase 2 |
What the finished NCT00274690 record still lists
NCT00274690 is an interventional study that assigns participants to a tested intervention. The registered 435 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (227% higher).
The record links to 0 conditions, and to 1 intervention - of which GW679769 is the first listed.
NCT00274690 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00274690 about?
NCT00274690 is a clinical study titled "Post-Operative Nausea And Vomiting Study In Female Patients". The primary purpose of this study is to determine an effective dose of this NK-1 anti-emetic medication to prevent nausea and vomiting in females after surgery.
What is the current status of trial NCT00274690?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 435 participants. The study started on 2005-02. Estimated completion is 2005-08.
What interventions are being tested in trial NCT00274690?
The interventions under investigation include: GW679769 (DRUG).
Who is sponsoring clinical trial NCT00274690?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00274690's enrollment target sits among peer trials
435 90th of 2000 higher than 1,911 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05563220 · 435 participants · Phase 1
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
- NCT07088926 · 435 participants · Phase 2
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
- NCT02622542 · 436 participants · NA
ACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy
- NCT05918211 · 436 participants · Phase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia